Medtronic - MDT Stock Forecast, Price & News

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 1 sell rating, 14 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
View MDT analyst ratings or view top-rated stocks.

20 Wall Street research analysts have issued 12-month target prices for Medtronic's stock. Their MDT share price forecasts range from $77.00 to $135.00. On average, they predict the company's stock price to reach $94.25 in the next year. This suggests a possible upside of 8.2% from the stock's current price.
View analysts price targets for MDT or view top-rated stocks among Wall Street analysts.

Medtronic's stock was trading at $77.72 at the beginning of the year. Since then, MDT stock has increased by 12.1% and is now trading at $87.10.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our MDT earnings forecast.

Medtronic will be holding an earnings conference call on Tuesday, February 21st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Medtronic plc (NYSE:MDT) posted its quarterly earnings data on Tuesday, November, 22nd. The medical technology company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The medical technology company earned $7.59 billion during the quarter, compared to analysts' expectations of $7.70 billion. Medtronic had a net margin of 14.03% and a trailing twelve-month return on equity of 13.52%. The firm's revenue for the quarter was down 3.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 EPS.
Read the conference call transcript.

Medtronic announced a quarterly dividend on Thursday, December 8th. Shareholders of record on Wednesday, December 21st will be given a dividend of $0.68 per share on Friday, January 13th. This represents a $2.72 dividend on an annualized basis and a yield of 3.12%. The ex-dividend date of this dividend is Tuesday, December 20th.
Read our dividend analysis for MDT.

Medtronic (NYSE:MDT) pays an annual dividend of $2.72 per share and currently has a dividend yield of 3.12%. The company has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 84.47%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MDT will have a dividend payout ratio of 50.00% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDT.

Medtronic updated its FY 2023 earnings guidance on Thursday, December, 22nd. The company provided EPS guidance of $5.25-$5.30 for the period, compared to the consensus earnings per share estimate of $5.53. The company issued revenue guidance of -.

1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Medtronic's stock is owned by a variety of institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.28%), Fisher Asset Management LLC (0.25%), New York State Common Retirement Fund (0.22%), Bank of Montreal Can (0.20%), Fort Washington Investment Advisors Inc. OH (0.18%) and ProShare Advisors LLC (0.16%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Omar Ishrak, Plc Medtronic, Richard H Anderson, Richard H Anderson, Robert John White and Sean Salmon.
View institutional ownership trends.

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDT stock can currently be purchased for approximately $87.10.

Medtronic (NYSE:MDT) has a market capitalization of $115.86 billion and generates $31.69 billion in revenue each year. The medical technology company earns $5.04 billion in net income (profit) each year or $3.22 on an earnings per share basis.

The company employs 95,000 workers across the globe.

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for the company is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879.